Pfizer Confirms mRNA Vaccine Never Tested for Preventing COVID Transmission

Janine Small, President of International Developed Markets at Pfizer Testifies at EU Hearing on Covid 19

In a startling disclosure at the EU COVI Hearings in Brussels on the 10th of October 2022, Janine Small admitted in response to a question posed by Dutch MEP Robert Roos that the Pfizer mRNA vaccine was never tested or shown before its release, to impact the transmission of the SARS-NCOV2 virus. In other words, whether the vaccine did, prevent transmission of Covid from one person to another. You can follow the entire hearing via the EU Media Center or watch the embedded video below.

Depending on your location this video may take some time to load. You can use the link above to load the video in a separate browser window.

In response to the MEP’s question, if the Pfizer mRNA vaccine had ever been tested before its release to the general public on its ability to prevent Covid transmission, Ms. Small responded by admitting it hadn’t. If the comment is accurate, we must determine how this disclosure impacts trust in scientific exchange and public health.

“Regarding the question around did we know about stopping immunization before it entered the market…No., We have to really move at the speed of science to really understand what is taking place in the market.”

Small then continued to justify her answer and you can watch her full response above by forwarding the video to the timestamp of 15.31.

Roos then immediately took to social media at the conclusion of the hearing, questioning on what basis governments within the EU had justified Covid vaccine passports if the vaccine was unable to affect the transmissibility of the virus. The main reason that people were vaccinating to protect each other was based on a fiction.

From a medical perspective, this admission matters tremendously. If the vaccines offered little to no communal benefit of protection against the transmission of the virus, the justification for, for instance, vaccinating school children is questionable. The known risks of the vaccines and listed SAEs far outweigh the benefits to this population.

By extension, the same logic can be applied to young and healthy adults not at risk from any comorbidities. It would appear that the argument offered by Governments and Health bodies for the public to act in the interests of protecting their fellow citizens was nothing less than disingenuous. A fabrication designed to coerce public compliance, exposing yet another fundamental flaw in the global management of the Covid pandemic.

The need for these products in the high-risk population is clear. Covid can kill and it is critical that public health institutions enjoy the trust of the public for the health system to function effectively. Otherwise, communication breaks down, creating chaos. To discover more truths and fictions relating to mRNA vaccines, read this piece.


Medika Life has provided this material for your information. It is not intended to substitute for the medical expertise and advice of your health care provider(s). We encourage you to discuss any decisions about treatment or care with your health care provider. The mention of any product, service, or therapy is not an endorsement by Medika Life

Robert Turner, Founding Editor
Robert Turner, Founding Editor
Robert is a Founder of Medika Life. He is a published author and owner of MedKoin Healthcare Solutions. He lives between the Philippines and the UK. and is an outspoken advocate for human rights. Access to basic healthcare and eradicating racial and gender bias in medicine are key motivators behind the Medika website and reflect Robert's passion for accessible medical care globally.
More from this author